Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer

BACKGROUND: PREDICT (http://www.predict.nhs.uk) is a prognostication and treatment benefit tool for early breast cancer (EBC). The aim of this study was to incorporate the prognostic effect of KI67 status in a new version (v3), and compare performance with the Predict model that includes HER2 status...

Descripción completa

Detalles Bibliográficos
Autores principales: Wishart, Gordon C, Rakha, Emad, Green, Andrew, Ellis, Ian, Ali, Hamid Raza, Provenzano, Elena, Blows, Fiona M, Caldas, Carlos, Pharoah, Paul DP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265394/
https://www.ncbi.nlm.nih.gov/pubmed/25472026
http://dx.doi.org/10.1186/1471-2407-14-908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265394/
https://www.ncbi.nlm.nih.gov/pubmed/25472026
http://dx.doi.org/10.1186/1471-2407-14-908

Ejemplares similares